Review article: Possible beneficial effects of coffee on liver disease and function

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2007, Pages 1-8

  Cadden, I S H ^a   Partovi, N ^a   Yoshida, E M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CAFFEINE; GAMMA GLUTAMYLTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CHEMISTRY; CANCER RISK; COFFEE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; LIVER PROTECTION; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; VIRUS HEPATITIS;

EID: 34250005159     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03319.x     Document Type: Article

References (40)

1. CBS Sunday Morning 'Caffeine Nation', 7 September 2003. http://www.cbsnews.com
2. National Coffee Association Coffee Drinking Trends Survey 2000.
3. Specialty Coffee Association of America 1999 Market Report.
4. Nurminen ML, Niittynen L, Korpela R, Vapaatalo H. Coffee, caffeine and blood pressure: a critical review. Eur J Clin Nutr 1999 53 : 831 9.
5. Jec SH, He J, Appel LJ, et al. Coffee consumption and serum lipids; a meta-analysis of randomized controlled clinical trials. Am J Epidemol 2001 153 : 353 62.
6. de Bree A, Verschuren WM, Blom HJ, Krombout D. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 2001 154 : 150 4.
7. Kawachi I, Colditz GA, Stone CB. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J 1994 72 : 269 75.
8. Myers MG, Basinski A. Coffee and coronary heart disease. Arch Intern Med 1992 152 : 1767 72.
9. Salazar-Martinez E, Willett WC, Ascherio A, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004 140 : 1 8.
10. Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with risk of parkinsons disease. JAMA 2000 283 : 2674 9.
11. Arnesen E, Huseby NE, Brenn T, Try K. The Tromso Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest 1986 46 : 63 70.
12. Tanaka K, Tokunaga S, Kono S, et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998 27 : 438 43.
13. Honjo S, Kono S, Coleman MP, et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 2001 54 : 823 9.
14. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005 128 : 24 32.
15. Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006 166 : 1190 5.
16. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992 136 : 1248 57.
17. Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A, Collaborative SIDECIR Group. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 2001 11 : 458 65.
18. Gallus S, Tavani A, Negri E, La Vecchia C. Does coffee protect against liver cirrhosis? Ann Epidemiol 2002 12 : 202 5.
19. Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003 13 : 419 23.
20. La Vecchia C, Negri E, Cavalieri d'Oro L, Franceschi S. Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev 1998 7 : 315 20.
21. International Agency for Research on Cancer (IARC). Alcohol drinking. IARC Monogr Eval Carcinog Risks Hum 1988 44 : 258 9.
22. International Agency for Research on Cancer (IARC). Hepatitis viruses. IARC Monogr Eval Carcinog Risks Hum 1994 59 : 255.
23. Gelatti U, Covolo L, Franceschini M, et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 2005 42 : 528 34.
24. Inoue M, Yoshimi I, Sobue T, Tsugane S, JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005 97 : 293 300.
25. Pisani P, Parkin DN, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997 6 : 387 400.
26. Kurozawa Y, Ogimoto I, Shibata A, et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005 93 : 607 10.
27. Ohfuji S, Fukushima W, Tanaka T, et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chromic type C liver disease: a case-control study. Hepatol Res 2006 36 : 201 8.
28. Tanaka K, Hara M, Sakamoto T, et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci 2007 98 : 214 8.
29. Montella M, Polesel J, La Vecchia C, et al. Coffee and tea consumption and the risk of hepatocellular carcinoma in Italy. Int J Cancer 2007 120 : 1555 9.
30. Wahllander A, Renner E, Preisig R. Fasting plasma caffeine concentration. A guide to the severity of chronic liver disease. Scand J Gastroenterol 1985 20 : 1133 41.
31. Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006 46 : 101 23.
32. Sharp DS, Benowitz NL. Re: "Alcohol, smoking, coffee, and cirrhosis" and "coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan". Am J Epidemiol 1995 141 : 480 2.
33. Hosaka S, Kawa S, Aoki Y, et al. Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminoflluorene. Food Chem Toxicol 2001 39 : 557 61.
34. Tanaka T, Nishikawa A, Shima H, et al. Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci 1990 52 : 429 40.
35. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Shilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002 40 : 1155 63.
36. Huber WW, Prustomersky S, Delbanco E, et al. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by coffee components kahweol and cafestol. Arch Toxicol 2002 76 : 209 17.
37. Huber WW, Scharf G, Rossmanith W, et al. The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch Toxicol 2002 75 : 685 94.
38. Urgert R, Shulz AGM, Katan MB. Effects of cafestol and kahweol from coffee grounds on serum lipids and serum liver enzymes in humans. Am J Clin Nutr 1995 61 : 149 54.
39. Weusten-Van der Woum MPME, Katan MB, Viani R, et al. Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function. J Lipid Res 1994 35 : 721 33.
40. McCusker RR, Goldberger BA, Cone EJ. Caffeine content of specialty coffees. Anal Toxicol 2003 27 : 520 2.